Thromb Haemost 2010; 103(04): 849-854
DOI: 10.1160/TH08-09-0564
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism

Nadine S. Gibson
1   Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands
,
Renee A. Douma
1   Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands
,
Alessandro Squizzato
2   Department of Clinical Medicine, University of Insubria, Varese, Italy
,
Maaike Sohne
1   Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands
,
Harry R. Buller
1   Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands
,
Victor E. A. Gerdes
1   Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands
3   Department of Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands
› Author Affiliations
Further Information

Publication History

Received: 11 September 2008

Accepted after major revision: 02 February 2010

Publication Date:
22 November 2017 (online)

Summary

Current strategies for diagnosing pulmonary embolism (PE) include a clinical decision rule (CDR), followed by a D-dimer assay in patients with an unlikely clinical probability. We assessed the implementation of the current guidelines for the diagnosis of PE. A first questionnaire was sent to internists and pulmonologists to assess the proportion of physicians that adequately applied the guidelines. Two versions of a second questionnaire were sent presenting five hypothetical cases of which in two cases with an intermediate clinical probability an abnormal D-dimer test result was added to one version. We assessed the variation of the CDR and compared the proportions of a likely clinical probability between the two versions. A total of 65 physicians responded to the first questionnaire (response rate 75%). Half of the physicians (N=29; 46%) indicated that they use a CDR in all patients and 22 physicians (45%) indicated that they review the D-dimer result after they examined patients. Sixty-two physicians responded on the second questionnaire (response rate 36%). A shift was observed from an unlikely to a likely probability when an abnormal D-dimer test result was added to the clinical information (22% to 41%; p=0.22 and 26% to 50%; p<0.05). Our findings indicate that physicians do not use the guidelines for diagnosis of PE consistently. Furthermore, the knowledge of an abnormal D-dimer test result before seeing the patient leads to a higher CDR score. Physicians should therefore first examine patients before taking note of the D-dimer test result.

 
  • References

  • 1 van Belle A, Buller HR, Huisman MV. et al. The Christopher study investigators.. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. J Am Med Assoc 2006; 29: 172-179.
  • 2 Perrier A, Roy PM, Aujesky D. et al. Diagnosing pulmonary embolism in out-patients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116: 291-299.
  • 3 Goekoop RJ, Steeghs N, Niessen RW. et al. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells’ simplified decision rule. Thromb Haemost 2007; 97: 146-150.
  • 4 Leclercq MG, Lutisan JG, van Marwijk KM. et al. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. Thromb Haemost 2003; 89: 97-103.
  • 5 Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007; 05 (Suppl. 01) 41-50.
  • 6 Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med 2003; 349: 1247-1256.
  • 7 Durieux P, Dhote R, Meyniard O. et al. D-dimer testing as the initial test for suspected pulmonary embolism. Appropriateness of prescription and physician compliance to guidelines. Thromb Res 2001; 101: 261-266.
  • 8 Gibson NS, Sohne M, Gerdes VE. et al. The importance of clinical probability assessment in interpreting a normal D-dimer in patients with suspected pulmonary embolism. Chest 2008; 134: 789-793.
  • 9 Wells PS, Anderson DR, Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-420.
  • 10 Ten Wolde M, Hagen PJ, Macgillavry MR. et al. Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. J Thromb Haemost 2004; 02: 1110-1117.
  • 11 Kruip MJ, Leclercq MG, van der Heul C. et al. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med 2003; 138: 941-951.
  • 12 Rodger MA, Maser E, Stiell I. et al. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism. Thromb Res 2005; 116: 101-107.
  • 13 Di Nisio M, Squizzato A, Rutjes AW. et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007; 05: 296-304.
  • 14 Roy PM, Meyer G, Vielle B. et al. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med 2006; 144: 157-164.
  • 15 Weiss CR, Haponik EF, Diette GB. et al. Pretest risk assessment in suspected acute pulmonary embolism. Acad Radiol 2008; 15: 3-14.
  • 16 Coppens M, van Mourik JA, Eckmann CM. et al. Current practise of testing for inherited thrombophilia. J Thromb Haemost 2007; 05: 1979-1981.
  • 17 Hagen PJ, van Strijen MJ, Kieft GJ. et al. The application of a Dutch consensus diagnostic strategy for pulmonary embolism in clinical practice. Neth J Med 2001; 59: 161-169.